Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
Clinical trial NCT00515944 · COMPLETED
Trial details
- NCT number
- NCT00515944
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.